Semple-type rabies vaccine
E1280885
UNEXPLORED
The Semple-type rabies vaccine is an early nerve-tissue–based rabies vaccine developed by British bacteriologist David Semple, historically used for post-exposure prophylaxis before modern cell-culture vaccines became standard.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Semple-type rabies vaccine canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T17665997 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Semple-type rabies vaccine Context triple: [David Semple, notableFor, Semple-type rabies vaccine]
-
A.
Spikevax
Spikevax is Moderna’s mRNA-based COVID-19 vaccine used worldwide to prevent infection and severe disease caused by the SARS-CoV-2 virus.
-
B.
rabies virus
Rabies virus is a deadly neurotropic virus that causes acute encephalitis in mammals, including humans, and is almost invariably fatal once clinical symptoms appear.
-
C.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
D.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
E.
Sendai virus vectors
Sendai virus vectors are non-integrating RNA viral delivery systems widely used to reprogram somatic cells into induced pluripotent stem cells by transiently expressing reprogramming factors.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Semple-type rabies vaccine Target entity description: The Semple-type rabies vaccine is an early nerve-tissue–based rabies vaccine developed by British bacteriologist David Semple, historically used for post-exposure prophylaxis before modern cell-culture vaccines became standard.
-
A.
Spikevax
Spikevax is Moderna’s mRNA-based COVID-19 vaccine used worldwide to prevent infection and severe disease caused by the SARS-CoV-2 virus.
-
B.
rabies virus
Rabies virus is a deadly neurotropic virus that causes acute encephalitis in mammals, including humans, and is almost invariably fatal once clinical symptoms appear.
-
C.
rVSV-ZEBOV
rVSV-ZEBOV is an experimental recombinant vesicular stomatitis virus-based vaccine developed to protect humans against infection by the Zaire strain of the Ebola virus.
-
D.
E*Vax
E*Vax is the stage name of Evan Mast, an American electronic musician and producer best known as one half of the duo Ratatat.
-
E.
Sendai virus vectors
Sendai virus vectors are non-integrating RNA viral delivery systems widely used to reprogram somatic cells into induced pluripotent stem cells by transiently expressing reprogramming factors.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.